APA

Veluchamy J. P., Heeren A. M., Spanholtz J., van Eendenburg J. D. H., Heideman D. A. M., Kenter G. G., Verheul H. M., van der Vliet H. J., Jordanova E. S. & de Gruijl T. D. (20170919). High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status. : Cancer immunology, immunotherapy : CII.

Chicago

Veluchamy John P, Heeren A Marijne, Spanholtz Jan, van Eendenburg Jaap D H, Heideman Daniëlle A M, Kenter Gemma G, Verheul Henk M, van der Vliet Hans J, Jordanova Ekaterina S and de Gruijl Tanja D. 20170919. High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status. : Cancer immunology, immunotherapy : CII.

Harvard

Veluchamy J. P., Heeren A. M., Spanholtz J., van Eendenburg J. D. H., Heideman D. A. M., Kenter G. G., Verheul H. M., van der Vliet H. J., Jordanova E. S. and de Gruijl T. D. (20170919). High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status. : Cancer immunology, immunotherapy : CII.

MLA

Veluchamy John P, Heeren A Marijne, Spanholtz Jan, van Eendenburg Jaap D H, Heideman Daniëlle A M, Kenter Gemma G, Verheul Henk M, van der Vliet Hans J, Jordanova Ekaterina S and de Gruijl Tanja D. High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status. : Cancer immunology, immunotherapy : CII. 20170919.